University of Missouri & University of Iowa Highlighting Human Health

Investments in agricultural research provide a boost to improve human health. With the sequencing of the swine (pig) genome, there are new opportunities to research with models that are extremely close to the human genome. The pig genome is of similar size, complexity, and chromosomal organization as the human genome and can be useful for human health studies.

USDA invested in the original research to map the swine genome. With NIH funding, scientists at the National Swine Resource and Research Center at University of Missouri, along with medical researchers from University of Iowa, are using the mapped swine genome to create swine models that are available to biomedical investigators. These models provide opportunities to develop cures for cystic fibrosis, lymphocytic leukemia, spina bifida, cardiovascular, and other diseases.  

Retaking The Field Volume 5 “Retaking the Field Volume 5: Innovation to Profit” explores how federally funded agricultural research strengthens farmers and ranchers’ bottomline by reducing costs and risks, increasing profits, and laying the groundwork for new products and industries. With powerful examples from universities across the country, it describes how research can generate outsized economic benefits that extends for decades. View The Issue
Retaking the Field Volume 5: Innovation to Profit Click to download report

More Stories from: Retaking The Field Volume 5

Winning With Wheat

Funded by USDA, the International Wheat Yield Partnership Coordinated Agricultural Project (CAP) and its predecessor Triticeae CAP (T-CAP) focused on improving wheat and barley for...

Read More
Building Blueberry Businesses

The Florida blueberry industry got its start in the 1970s when the University of Florida (UF) Institute of Food and Agricultural Sciences developed the first Southern Highbush blueberry...

Read More
Capitalizing on Cranberries

Both cranberries and blueberries are botanically part of the Vaccinium species. The U.S. Vaccinium industry’s domestic wholesale value exceeds $2 billion per year. Although production and...

Read More